All Stories

  1. CDKN2A homozygous deletions and TSC2 somatic mutations in metastatic pancreatic neuroendocrine tumors

    Article • npj Precision Oncology, December 2025, Springer Science + Business Media

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  2. Genetic Background Dictates the Dichotomous Effects of Bisphenol A on Thyroid Cell Viability, Proliferation, and Migration

    Article • November 2025, MDPI AG

    Paula Soares

  3. Patient-derived tumoroids recapitulate the morphologic and molecular features of pediatric brain tumors

    Article • npj Precision Oncology, November 2025, Springer Science + Business Media

    Paula Soares

  4. Unravelling the Tumourigenesis Mechanisms of Oncocytic Cell Tumours: Discoveries from a Comparative Omics Study

    Article • Pathobiology, October 2025, Karger Publishers

    Paula Soares

  5. DICER1 and DGCR8 in Thyroid Tumorigenesis: miRNA Biogenesis and Histopathologic Diversity

    Article • European Thyroid Journal, October 2025, Bioscientifica

    Paula Soares

  6. The Usefulness of Combined Digital Dermatoscopy and Ultrasound with Colour Doppler in the Diagnosis of Skin Lesions

    Article • Diagnostics, August 2025, MDPI AG

    Paula Soares

  7. Exploring MAPK and mTOR Pathways in Feline Thyroid Tumors

    Article • Veterinary Sciences, June 2025, MDPI AG

    Paula Soares

  8. Challenges of the 5th Edition of the WHO Classification of Thyroid Tumours

    Article • Endocrinology Insights, May 2025, Karger Publishers

    Paula Soares

  9. The hypothalamus-pituitary-thyroid axis is disrupted by exposure to a mix of tributyltin and bisphenol S

    Article • Environmental Pollution, March 2025, Elsevier

    Paula Soares

  10. Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology

    Article • Pharmaceutics, January 2025, MDPI AG

    Paula Soares

  11. Insights in biomarkers complexity and routine clinical practice for the diagnosis of thyroid nodules and cancer

    Article • PeerJ, January 2025, PeerJ

    Paula Soares

  12. Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment

    Article • Drug Delivery and Translational Research, January 2025, Springer Science + Business Media

    Paula Soares

  13. TERTmonitor Efficacy and Performance in Detecting Mutations by Droplet Digital PCR

    Article • Genes, October 2024, MDPI AG

    Paula Soares

  14. Biomarker Profiling of Upper Tract Urothelial Carcinoma Only and with Synchronous or Metachronous Bladder Cancer

    Article • Biomedicines, September 2024, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  15. Exploring the genetic links between voltage-gated potassium channels and familial non-medullary thyroid carcinoma: a family study

    Article • Endocrine Abstracts, August 2024, Bioscientifica

    Paula Soares

  16. Genomic profiling of lymph node and distant metastases from papillary and poorly differentiated thyroid carcinomas

    Article • Endocrine, July 2024, Springer Science + Business Media

    Paula Soares

  17. The relationship between the gut microbiota and thyroid disorders

    Article • Nature Reviews Endocrinology, June 2024, Springer Science + Business Media

    Paula Soares

  18. MODL-08. PATIENT-DERIVED ORGANOIDS RECAPITULATE THE MOLECULAR LANDSCAPE OF PEDIATRIC BRAIN TUMORS

    Article • Neuro-Oncology, June 2024, Oxford University Press (OUP)

    Paula Soares

  19. Unraveling the Significance of DGCR8 and miRNAs in Thyroid Carcinoma

    Article • Cells, March 2024, MDPI AG

    Paula Soares

  20. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas

    Article • Genes, March 2024, MDPI AG

    Paula Soares

  21. Cyto-Histological Profile of microRNAs as Diagnostic Biomarkers in Differenciated Thyroid Carcinomas

    Article • February 2024, MDPI AG

    Paula Soares

  22. Urine-Based Biomarker Test Uromonitor® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer—A Systematic Review and Meta-Analysis of Diagnostic Test Performance

    Article • Cancers, February 2024, MDPI AG

    Paula Soares

  23. The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms

    Article • Endocrine Pathology, January 2024, Springer Science + Business Media

    Paula Soares

  24. Comparative Cyto-Histological Genetic Profile in a Series of Differentiated Thyroid Carcinomas

    Article • Diagnostics, January 2024, MDPI AG

    Paula Soares

  25. Investigating USP42 Mutation as Underlying Cause of Familial Non-Medullary Thyroid Carcinoma

    Article • International Journal of Molecular Sciences, January 2024, MDPI AG

    Paula Soares

  26. Pyriproxyfen, villain or good guy? A brief review

    Article • Archives of Endocrinology and Metabolism, January 2024, Archives of Endocrinology and Metabolism

    Paula Soares

  27. Comparative Cyto-histological Genetic Profile in a Series of Differentiated Thyroid Carcinomas

    Article • December 2023, MDPI AG

    Paula Soares

  28. Genomic profiling of primary and metastatic thyroid cancers

    Article • Endocrine Related Cancer, November 2023, Bioscientifica

    Paula Soares

  29. Subcentimetric Papillary Thyroid Carcinoma: Does the Diagnosis Kind Impact Prognosis?

    Article • Cureus, November 2023, Springer Science + Business Media

    Paula Soares

  30. Environmental Endocrinology: Parabens Hazardous Effects on Hypothalamic–Pituitary–Thyroid Axis

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Paula Soares

  31. Subcentimetric papillary thyroid carcinoma with extensive lymph node and brain metastasis: case report and review of literature

    Article • Endocrinology Diabetes and Metabolism Case Reports, October 2023, Bioscientifica

    Paula Soares

  32. TERTmonitor—qPCR Detection of TERTp Mutations in Glioma

    Article • Genes, August 2023, MDPI AG

    Paula Soares

  33. Environmental Endocrinology: Parabens Hazardous Effects on HPT Axis

    Article • August 2023, MDPI AG

    Paula Soares

  34. Significance of Furin Expression in Thyroid Neoplastic Transformation

    Article • Cancers, August 2023, MDPI AG

    Paula Soares

  35. Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments

    Article • Journal of Personalized Medicine, July 2023, MDPI AG

    Paula Soares

  36. Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma

    Article • International Journal of Molecular Sciences, July 2023, MDPI AG

    Paula Soares

  37. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management

    Article • European Thyroid Journal, June 2023, Bioscientifica

    Paula Soares

  38. Generation of an Obese Diabetic Mouse Model upon Conditional Atrx Disruption

    Article • Cancers, June 2023, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  39. Abstract

    Article • European Journal of Clinical Investigation, May 2023, Wiley

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  40. High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma

    Article • Cancers, April 2023, MDPI AG

    Paula Soares

  41. Survey on selenium clinical supplementation in autoimmune thyroid disease

    Article • European Thyroid Journal, April 2023, Bioscientifica

    Paula Soares

  42. Assessing the Antitumor Potential of Variants of the Extracellular Carbohydrate Polymer from Synechocystis ΔsigF Mutant

    Article • Polymers, March 2023, MDPI AG

    Paula Soares

  43. Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas

    Article • Genes, February 2023, MDPI AG

    Paula Soares

  44. Endocrine-disrupting chemicals and endocrine neoplasia: A forty-year systematic review

    Article • Environmental Research, February 2023, Elsevier

    Paula Soares

  45. Yoga for COVID-19: An ancient practice for a new condition – A literature review

    Article • Complementary Therapies in Clinical Practice, February 2023, Elsevier

    Paula Soares

  46. Non-invasive follicular thyroid neoplasm with papillary-like nuclear feature: clinical, pathological, and molecular update 5 years after the nomenclature revision

    Article • European Journal of Endocrinology, January 2023, Oxford University Press (OUP)

    Paula Soares

  47. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma

    Article • Diagnostics, January 2023, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  48. Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma

    Article • European Journal of Cancer, January 2023, Elsevier

    Paula Soares

  49. An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms

    Article • Endocrine Related Cancer, December 2022, Bioscientifica

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  50. DGCR8 Microprocessor Subunit Mutation and Expression Deregulation in Thyroid Lesions

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Paula Soares

  51. Case Report: Composite pheochromocytoma with ganglioneuroma component: A report of three cases

    Article • Frontiers in Endocrinology, September 2022, Frontiers

    Paula Soares

  52. HuRthle cell tumors vs oncocytic variants of the follicular cell derived thyroid tumours: a comprehensive analysis based in transcriptome, proteome and cnv profiling

    Article • Endocrine Abstracts, September 2022, Bioscientifica

    Paula Soares

  53. Tackling Thyroid Cancer in Europe—The Challenges and Opportunities

    Article • Healthcare, August 2022, MDPI AG

    Paula Soares

  54. Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour

    Article • Cancers, August 2022, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  55. Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series

    Article • European Thyroid Journal, August 2022, Bioscientifica

    Paula Soares

  56. Environmentally relevant dose of the endocrine disruptor tributyltin disturbs redox balance in female thyroid gland

    Article • Molecular and Cellular Endocrinology, August 2022, Elsevier

    Paula Soares

  57. Aggressive nonfunctioning pituitary neuroendocrine tumors

    Article • Brain Tumor Pathology, June 2022, Springer Science + Business Media

    Paula Soares

  58. Connexin Expression in Pituitary Adenomas and the Effects of Overexpression of Connexin 43 in Pituitary Tumor Cell Lines

    Article • Genes, April 2022, MDPI AG

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  59. Subacute and low-dose tributyltin exposure disturbs the mammalian hypothalamus-pituitary-thyroid axis in a sex-dependent manner

    Article • Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology, April 2022, Elsevier

    Paula Soares

  60. Post-COVID-19 Condition: Where Are We Now?

    Article • Life, March 2022, MDPI AG

    Paula Soares

  61. The ringworm campaign in Portugal, 1940–1970

    Article • February 2022, Oxford University Press (OUP)

    Paula Soares

  62. Performance of the Bethesda System for Reporting Thyroid Cytology in Multi-Institutional Large Cohort of Pediatric Thyroid Nodules: A Detailed Analysis

    Article • Diagnostics, January 2022, MDPI AG

    Paula Soares

  63. The Multifaceted Profile of Thyroid Disease in the Background of DICER1 Germline and Somatic Mutations: Then, Now and Future Perspectives

    Article • Journal of Molecular Pathology, January 2022, MDPI AG

    Paula Soares

  64. Predictive Biomarkers in Melanoma: Detection of BRAF Mutation Using Dermoscopy

    Article • January 2022, Springer Science + Business Media

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  65. <b><i>TERT</i></b> Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy

    Article • Dermatology, September 2021, Karger Publishers

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  66. Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes

    Article • Pharmaceuticals, August 2021, MDPI AG

    Paula Soares

  67. LRP1B: A Giant Lost in Cancer Translation

    Article • Pharmaceuticals, August 2021, MDPI AG

    Paula Soares

  68. DGCR8 microprocessor defect and deregulation of its expression in thyroid cancer

    Article • European Journal of Public Health, August 2021, Oxford University Press (OUP)

    Paula Soares

  69. Indeterminate thyroid cytology: detecting malignancy using analysis of nuclear images

    Article • Endocrine Connections, July 2021, Bioscientifica

    Paula Soares

  70. Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application

    Article • Frontiers in Endocrinology, May 2021, Frontiers

    Paula Soares

  71. TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  72. Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study

    Article • Journal of Experimental Pharmacology, May 2021, Taylor & Francis

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  73. Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma

    Article • Cancers, April 2021, MDPI AG

    Paula Soares

  74. Integrated Metabolomics and Transcriptomics Analysis of Monolayer and Neurospheres from Established Glioblastoma Cell Lines

    Article • Cancers, March 2021, MDPI AG

    Paula Soares

  75. The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab

    Article • Scientific Reports, March 2021, Springer Science + Business Media

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  76. Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification

    Article • Endocrine Pathology, March 2021, Springer Science + Business Media

    Paula Soares

  77. Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma

    Article • Journal of Endocrinological Investigation, February 2021, Springer Science + Business Media

    Paula Soares

  78. LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer

    Article • Pathobiology, January 2021, Karger Publishers

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  79. Osteopontin-a enhances cytoskeleton remodeling and activates intermediate epithelial mesenchymal properties in c643 thryoid cancer cells

    Article • January 2021, Bio-Manguinhos Fiocruz

    Paula Soares

  80. Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons

    Article • Dermatologic Therapy, December 2020, Wiley

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  81. S616-p-DRP1 associates with locally invasive behavior of follicular cell-derived thyroid carcinoma

    Article • Endocrine, November 2020, Springer Science + Business Media

    Paula Soares

  82. Clinicopathological Features as Prognostic Predictors of Poor Outcome in Papillary Thyroid Carcinoma

    Article • Cancers, October 2020, MDPI AG

    Paula Soares

  83. Molecular Aspects of Thyroid Calcification

    Article • International Journal of Molecular Sciences, October 2020, MDPI AG

    Paula Soares

  84. Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment

    Article • European Journal of Cancer, October 2020, Elsevier

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  85. Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

    Article • Diagnostics, September 2020, MDPI AG

    Paula Soares

  86. Follicular Lesions with Papillary Nuclear Characteristics: Differences in Chromatin Detected by Computerized Image Analysis

    Article • Archives of Endocrinology and Metabolism, August 2020, Archives of Endocrinology and Metabolism

    Paula Soares

  87. Analyzing the Role of DICER1 Germline Variations in Papillary Thyroid Carcinoma

    Article • European Thyroid Journal, August 2020, Karger Publishers

    Paula Soares

  88. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer

    Article • Diagnostics, July 2020, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  89. Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours

    Article • Cancers, July 2020, MDPI AG

    Paula Soares

  90. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas

    Article • Genes, July 2020, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  91. Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”

    Article • International Journal of Endocrinology, June 2020, Hindawi Publishing Corporation

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  92. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome

    Article • Cancers, May 2020, MDPI AG

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  93. Evaluation of the role of mitochondria in the non-targeted effects of ionizing radiation using cybrid cellular models

    Article • Scientific Reports, April 2020, Springer Science + Business Media

    Paula Soares

  94. Reliable blood cancer cells' telomere length evaluation by qPCR

    Article • Cancer Medicine, March 2020, Wiley

    Paula Soares

  95. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?

    Article • Acta Otorhinolaryngologica Italica, February 2020, Pacini Editore

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  96. Relevant dose of the environmental contaminant, tributyltin, promotes histomorphological changes in the thyroid gland of male rats

    Article • Molecular and Cellular Endocrinology, February 2020, Elsevier

    Paula Soares

  97. TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients

    Article • International Journal of Molecular Sciences, January 2020, MDPI AG

    Paula Soares, Professor Luis Lima

  98. Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review

    Article • Diagnostics, January 2020, MDPI AG

    Paula Soares

  99. Cancer incidence after childhood irradiation for tinea capitis in a Portuguese cohort

    Article • British Journal of Radiology, January 2020, British Institute of Radiology

    Paula Soares

  100. Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study

    Article • Frontiers in Genetics, December 2019, Frontiers

    Paula Soares

  101. Variants of Papillary Thyroid Carcinoma: An Algorithmic Cytomorphology-Based Approach to Cytology Specimens

    Article • Acta Cytologica, October 2019, Karger Publishers

    Professor Fernando Schmitt, Paula Soares

  102. Predicting Growing Stock Volume of Eucalyptus Plantations Using 3-D Point Clouds Derived from UAV Imagery and ALS Data

    Article • Forests, October 2019, MDPI AG

    Paula Soares

  103. Characterization and antitumor activity of the extracellular carbohydrate polymer from the cyanobacterium Synechocystis ΔsigF mutant

    Article • International Journal of Biological Macromolecules, September 2019, Elsevier

    Paula Soares

  104. Interaction of Genetic Variations inNFE2L2andSELENOSModulates the Risk of Hashimoto's Thyroiditis

    Article • Thyroid, September 2019, Mary Ann Liebert Inc

    Paula Soares, DAVIDE CARVALHO

  105. Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism

    Article • International Journal of Endocrinology, August 2019, Hindawi Publishing Corporation

    Ana P Santos, MD, PhD,IFCAP José Manuel Lopes, Paula Soares, BERNARDO DIAS PEREIRA, Fernando Rodrigues

  106. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors

    Article • Molecular and Cellular Endocrinology, June 2019, Elsevier

    Paula Soares

  107. Oncocytic thyroid neoplasms: from histology to molecular biology

    Article • Diagnostic Histopathology, May 2019, Elsevier

    Paula Soares

  108. “The other side of the coin”: understanding noninvasive follicular tumor with papillary-like nuclear features in unifocal and multifocal settings

    Article • Human Pathology, April 2019, Elsevier

    Paula Soares

  109. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma

    Article • Journal of the American Academy of Dermatology, March 2019, Elsevier

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  110. TERT promoter and FGFR3 mutations – a highly sensitive and non-invasive tool for bladder cancer recurrence detection

    Article • European Urology Supplements, March 2019, Elsevier

    Paula Soares

  111. Scalp basal cell carcinoma: A different entity?

    Article • Dermatologic Therapy, January 2019, Wiley

    Paula Soares

  112. Tendências do carcinoma espinocelular cutâneo no Hospital de Gaia (2004-20013)

    Article • Journal of the Portuguese Society of Dermatology and Venereology, October 2018, Portuguese Society of Dermatology and Venereology

    Paula Soares

  113. Selenium and Selenoproteins in Immune Mediated Thyroid Disorders

    Article • Diagnostics, October 2018, MDPI AG

    Paula Soares

  114. The environmental contaminant tributyltin leads to abnormalities in different levels of the hypothalamus-pituitary-thyroid axis in female rats

    Article • Environmental Pollution, October 2018, Elsevier

    Paula Soares

  115. OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines

    Article • International Journal of Molecular Sciences, September 2018, MDPI AG

    Paula Soares

  116. Uromonitor®as a novel sensitive and specific urine-based test for recurrence surveillance of patients with non-muscle invasive bladder cancer

    Article • September 2018, Cold Spring Harbor Laboratory Press

    Paula Soares

  117. The genetics of cutaneous squamous cell carcinogenesis

    Article • European Journal of Dermatology, September 2018, John Libbey Eurotext

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  118. Liposomal therapies in oncology: does one size fit all?

    Article • Cancer Chemotherapy and Pharmacology, August 2018, Springer Science + Business Media

    Paula Soares

  119. Editorial on “The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma”

    Article • Translational Cancer Research, August 2018, AME Publishing Company

    Paula Soares

  120. Follicular thyroid lesions: is there a discriminatory potential in the computerized nuclear analysis?

    Article • Endocrine Connections, August 2018, Bioscientifica

    Paula Soares

  121. Unraveling molecular targets of bisphenol A and S in the thyroid gland

    Article • Environmental Science and Pollution Research, July 2018, Springer Science + Business Media

    Jones Graceli, Paula Soares

  122. Abstract 180: OPNa variant expression is associated with matrix mineralization in thyroid cancer cell lines

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Paula Soares

  123. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma

    Article • Endocrine, June 2018, Springer Science + Business Media

    Paula Soares

  124. Melanoma treatment in review

    Article • ImmunoTargets and Therapy, June 2018, Dove Medical Press

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  125. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway

    Article • Modern Pathology, May 2018, Springer Science + Business Media

    Paula Soares

  126. mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression

    Article • International Journal of Molecular Sciences, May 2018, MDPI AG

    Paula Soares

  127. Age-Associated Mortality Risk in Papillary Thyroid Cancer: Does BRAF Make a Real Difference?

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    Paula Soares

  128. Telomere Maintenance Mechanisms in Cancer

    Article • Genes, May 2018, MDPI AG

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  129. Tributyltin and Zebrafish: Swimming in Dangerous Water

    Article • Frontiers in Endocrinology, April 2018, Frontiers

    Paula Soares

  130. Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background

    Article • Mitochondrion, April 2018, Elsevier

    Valdemar Máximo, Paula Soares

  131. Is Low-Dose Radiation Exposure a Risk Factor for Atherosclerotic Disease?

    Article • Radiation Research, April 2018, Radiation Research Society

    Paula Soares

  132. Multinodular Goiter Progression Toward Malignancy in a Case of DICER1 Syndrome

    Article • American Journal of Clinical Pathology, March 2018, Oxford University Press (OUP)

    Paula Soares

  133. Dynamin-Related Protein 1 at the Crossroads of Cancer

    Article • Genes, February 2018, MDPI AG

    Valdemar Máximo, Paula Soares

  134. CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension

    Article • BMC Cancer, January 2018, Springer Science + Business Media

    Paula Soares

  135. NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features

    Article • Endocrine Connections, January 2018, Bioscientifica

    Paula Soares

  136. Frontiers in endocrine disruption: Impacts of organotin on the hypothalamus-pituitary-thyroid axis

    Article • Molecular and Cellular Endocrinology, January 2018, Elsevier

    Paula Soares

  137. Etiopathogenesis of oncocytomas

    Article • Seminars in Cancer Biology, December 2017, Elsevier

    Valdemar Máximo, Paula Soares

  138. Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer

    Article • Hormones and Cancer, September 2017, Springer Science + Business Media

    Paula Soares

  139. Calcitonin receptor expression in medullary thyroid carcinoma

    Article • PeerJ, September 2017, PeerJ

    Paula Soares

  140. Introduction

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  141. Other Rare Tumours and Tumour-Like Lesions

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  142. Rare Familial Tumours

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  143. Rare Follicular Tumours

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  144. Rare Papillary Thyroid Carcinomas

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  145. Small Cell Tumours

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  146. Therapeutic Options

    Article • July 2017, Springer Science + Business Media

    Paula Soares

  147. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma

    Article • PLOS One, June 2017, PLOS

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  148. Hobnail Variant of Papillary Thyroid Carcinoma

    Article • The American Journal of Surgical Pathology, June 2017, Wolters Kluwer Health

    Paula Soares

  149. Telomerase and N-Cadherin in Adrenocortical Tumors

    Article • Journal of Cellular Biochemistry, April 2017, Wiley

    Duarte Pignatelli, Valdemar Máximo, Paula Soares, Susana Gomes Gomes Guerreiro

  150. The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications

    Article • Current Genomics, April 2017, Bentham Science Publishers

    Paula Soares

  151. Molecular landscape of metastatic thyroid cancer

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2017, Endocrine Society

    Miguel Melo, Cristina Ribeiro, Paula Soares

  152. The role of ablative treatment in differentiated thyroid cancer management

    Article • Expert Review of Endocrinology & Metabolism, February 2017, Taylor & Francis

    Paula Soares

  153. TERTbiology and function in cancer: beyond immortalisation

    Article • Journal of Molecular Endocrinology, January 2017, Bioscientifica

    Paula Soares

  154. Molecular study on some antibiotic resistant genes in Salmonella spp. isolates

    Article • January 2017, American Institute of Physics

    Paula Soares

  155. The biology and the genetics of Hürthle cell tumors of the thyroid

    Article • Endocrine Related Cancer, December 2016, Bioscientifica

    Paula Soares

  156. In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp

    Article • Endocrine Related Cancer, December 2016, Bioscientifica

    Paula Soares

  157. pmTOR is a marker of aggressiveness in papillary thyroid carcinomas

    Article • Surgery, December 2016, Elsevier

    Paula Soares

  158. TERTpromoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation

    Article • European Journal of Endocrinology, October 2016, Bioscientifica

    Paula Boaventura, Paula Soares

  159. IL6-174 G>C Polymorphism (rs1800795) Association with Late Effects of Low Dose Radiation Exposure in the Portuguese Tinea Capitis Cohort

    Article • PLOS One, September 2016, PLOS

    Paula Soares

  160. The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype

    Article • Genes, September 2016, MDPI AG

    Paula Soares

  161. Telomerase Activation in Hematological Malignancies

    Article • Genes, September 2016, MDPI AG

    Paula Soares

  162. Erratum: Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

    Article • Oncogene, August 2016, Springer Science + Business Media

    Paula Soares

  163. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes

    Article • Scientific Reports, July 2016, Springer Science + Business Media

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  164. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior

    Article • Oncotarget, July 2016, Impact Journals, LLC

    Paula Soares

  165. Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”

    Article • Journal of Thyroid Research, June 2016, Wiley

    Paula Soares

  166. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas

    Article • Melanoma Research, April 2016, Wolters Kluwer Health

    Paula Soares

  167. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism

    Article • International Journal of Cancer, March 2016, Wiley

    Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  168. Telomerase promoter mutations in cancer: beyond immortalization?

    Article • Endocrine Abstracts, February 2016, Bioscientifica

    Paula Soares

  169. TERT promoter mutations in pancreatic endocrine tumours are frequent in tumours from patients with hereditary syndromes

    Article • Endocrine Abstracts, February 2016, Bioscientifica

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  170. Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma

    Article • January 2016, Bioscientifica

    Paula Soares

  171. TERT Promoter Mutations in Soft Tissue Sarcomas

    Article • The International Journal of Biological Markers, January 2016, SAGE Publications

    Dr. Rui M Reis, Paula Soares

  172. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2016, Endocrine Society

    Dr David Viola, Paula Soares

  173. Thyroid and Parathyroid Glands

    Article • January 2016, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  174. Obesity Is Associated With Low NAD+/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2016, Endocrine Society

    Paula Soares, Professor Alfred King Lam

  175. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes

    Article • Cytogenetic and Genome Research, January 2016, Karger Publishers

    Paula Soares

  176. Hotspot TERT promoter mutations are rare events in testicular germ cell tumors

    Article • Tumor Biology, November 2015, Springer Science + Business Media

    Paula Soares, Dr. Fatima Baltazar

  177. RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation

    Article • Molecular and Cellular Endocrinology, November 2015, Elsevier

    Paula Soares

  178. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome

    Article • October 2015, Bioscientifica

    Paula Soares

  179. ESP Abstracts 2015

    Article • Virchows Archiv, August 2015, Springer Science + Business Media

    Paula Soares

  180. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy

    Article • Expert Opinion on Therapeutic Targets, May 2015, Informa Healthcare

    Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  181. Mitochondrial Dynamics Protein Drp1 Is Overexpressed in Oncocytic Thyroid Tumors and Regulates Cancer Cell Migration

    Article • PLOS One, March 2015, PLOS

    Valdemar Máximo, Paula Soares, Professor Luca Scorrano

  182. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

    Article • JNCI Journal of the National Cancer Institute, March 2015, Oxford University Press (OUP)

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  183. Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis?

    Article • Journal of Clinical Oncology, February 2015, American Society of Clinical Oncology (ASCO)

    Paula Soares

  184. Hashimoto’s Thyroiditis in Adolescents

    Article • US Endocrinology, January 2015, Touch Digital Media, Ltd.

    Paula Soares

  185. Poorly differentiated and undifferentiated thyroid carcinomas

    Article • Turkish Journal of Pathology, January 2015, Federation of Turkish Pathology Societies

    Paula Soares

  186. OXPHOS dysfunction regulates integrin- 1 modifications and enhances cell motility and migration

    Article • Human Molecular Genetics, December 2014, Oxford University Press (OUP)

    Valdemar Máximo, Paula Soares

  187. mTOR activation in medullary thyroid carcinoma with RAS mutation

    Article • European Journal of Endocrinology, November 2014, Bioscientifica

    Paula Soares

  188. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)

    Article • European Journal of Human Genetics, September 2014, Springer Science + Business Media

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  189. Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature

    Article • Frontiers in Molecular Biosciences, September 2014, Frontiers

    Paula Soares

  190. Thyroid and parathyroid tumours in patients submitted to X-ray scalp epilation during the tinea capitis eradication campaign in the North of Portugal (1950–1963)

    Article • Virchows Archiv, August 2014, Springer Science + Business Media

    Paula Soares

  191. Polymorphisms in the TNFA and IL6 Genes Represent Risk Factors for Autoimmune Thyroid Disease

    Article • PLOS One, August 2014, PLOS

    Paula Soares

  192. TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation

    Article • Journal of Investigative Dermatology, August 2014, Elsevier

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  193. Telomerase promoter mutations in cancer: an emerging molecular biomarker?

    Article • Virchows Archiv, July 2014, Springer Science + Business Media

    Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  194. Increased lymphangiogenesis in Riedel thyroiditis (Immunoglobulin G4-related thyroid disease)

    Article • Virchows Archiv, July 2014, Springer Science + Business Media

    Paula Soares

  195. TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2014, Endocrine Society

    Valdemar Máximo, Paula Soares

  196. A Polymorphism in the Promoter Region of the Selenoprotein S Gene (SEPS1) Contributes to Hashimoto's Thyroiditis Susceptibility

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2014, Endocrine Society

    Paula Soares, DAVIDE CARVALHO

  197. C-Cell-Derived Calcitonin-Free Neuroendocrine Carcinoma of the Thyroid

    Article • International Journal of Surgical Pathology, March 2014, SAGE Publications

    Paula Soares

  198. Prognostic biomarkers in thyroid cancer

    Article • Virchows Archiv, February 2014, Springer Science + Business Media

    Paula Soares

  199. Papillary Thyroid Microcarcinoma

    Article • International Journal of Surgical Pathology, January 2014, SAGE Publications

    Paula Soares

  200. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas

    Article • Journal of Dermatological Science, January 2014, Elsevier

    Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  201. Primary Squamous Cell Carcinoma of the Thyroid Diagnosed as Anaplastic Carcinoma: Failure in Fine-Needle Aspiration Cytology?

    Article • Case Reports in Pathology, January 2014, Hindawi Publishing Corporation

    Paula Soares

  202. Stimulated Thyroglobulin at Recombinant Human TSH-Aided Ablation Predicts Disease-free Status One Year Later

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2013, Endocrine Society

    Miguel Melo, Paula Soares

  203. Abstract C118: TERT promoter mutations in human gliomas.

    Article • Molecular Cancer Therapeutics, November 2013, American Association for Cancer Research (AACR)

    Paula Soares

  204. A founder SDHB mutation in Portuguese paraganglioma patients

    Article • October 2013, Bioscientifica

    Valdemar Máximo, Paula Soares

  205. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment

    Article • August 2013, Bioscientifica

    Paula Boaventura, Paula Soares

  206. Nrf2 Is Commonly Activated in Papillary Thyroid Carcinoma, and It Controls Antioxidant Transcriptional Responses and Viability of Cancer Cells

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2013, Endocrine Society

    Paula Soares

  207. Frequency of TERT promoter mutations in human cancers

    Article • Nature Communications, July 2013, Springer Science + Business Media

    Professor Luis Lima, Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  208. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells

    Article • PeerJ, July 2013, PeerJ

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  209. Etiopathogenic factors of thyroid cancer

    Article • June 2013, Future Medicine

    Paula Soares

  210. Radiotherapy: radioiodine and external beam irradiation treatment of differentiated thyroid carcinomas

    Article • June 2013, Future Medicine

    Paula Soares

  211. Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features

    Article • International Journal of Surgical Pathology, January 2013, SAGE Publications

    Paula Soares

  212. CDX2 Expression in Some Variants of Papillary Thyroid Carcinoma

    Article • American Journal of Clinical Pathology, December 2012, Oxford University Press (OUP)

    Paula Soares

  213. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism

    Article • October 2012, Bioscientifica

    Paula Soares

  214. AZD1480 Blocks Growth and Tumorigenesis of RET- Activated Thyroid Cancer Cell Lines

    Article • PLOS One, October 2012, PLOS

    Paula Soares

  215. Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes

    Article • Genes Chromosomes and Cancer, September 2012, Wiley

    Paula Soares

  216. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors

    Article • European Journal of Human Genetics, September 2012, Nature

    Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  217. STAT3 negatively regulates thyroid tumorigenesis

    Article • Proceedings of the National Academy of Sciences, August 2012, Proceedings of the National Academy of Sciences

    Valdemar Máximo, Paula Soares

  218. RET/PTCrearrangement is prevalent in follicular Hürthle cell carcinomas

    Article • Histopathology, July 2012, Wiley

    Valdemar Máximo, Paula Soares

  219. mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2012, Endocrine Society

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  220. 1121 BRAF Mutations in Thyroid Carcinomas Following Childhood Scalp Irradiation

    Article • European Journal of Cancer, July 2012, Elsevier

    Paula Soares

  221. Insights into melanoma: targeting the mTOR pathway for therapeutics

    Article • Expert Opinion on Therapeutic Targets, May 2012, Informa Healthcare

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  222. TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma

    Article • Virchows Archiv, April 2012, Springer Science + Business Media

    Paula Soares

  223. The biology and the genetics of Hurthle cell tumors of the thyroid

    Article • April 2012, Bioscientifica

    Valdemar Máximo, Paula Soares

  224. Absence of theBRAFand theGRIM-19Mutations in Oncocytic (Hürthle Cell) Solid Cell Nests of the Thyroid

    Article • American Journal of Clinical Pathology, April 2012, Oxford University Press (OUP)

    Valdemar Máximo, Paula Soares

  225. Head and neck basal cell carcinoma prevalence in individuals submitted to childhood X-ray epilation for tinea capitis treatment

    Article • European Journal of Dermatology, March 2012, John Libbey Eurotext

    Paula Soares

  226. The mTOR Signalling Pathway in Human Cancer

    Article • International Journal of Molecular Sciences, February 2012, MDPI AG

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  227. Melanocytic Tumour in a Black Sheep never exposed to Ultraviolet Radiation

    Article • Journal of Comparative Pathology, February 2012, Elsevier

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  228. A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease

    Article • Case Reports in Ophthalmology, January 2012, Karger Publishers

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  229. Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review

    Article • Sao Paulo Medical Journal, January 2012, FapUNIFESP (SciELO)

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  230. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad

    Article • Familial Cancer, December 2011, Springer Science + Business Media

    Valdemar Máximo, Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  231. Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

    Article • Current Genomics, December 2011, Bentham Science Publishers

    Valdemar Máximo, Paula Soares

  232. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma

    Article • Virchows Archiv, November 2011, Springer Science + Business Media

    Paula Soares

  233. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome

    Article • Cancer Epidemiology Biomarkers & Prevention, September 2011, American Association for Cancer Research (AACR)

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  234. GRIM-19 function in cancer development

    Article • Mitochondrion, September 2011, Elsevier

    Valdemar Máximo, Paula Soares

  235. Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR

    Article • Life Sciences, September 2011, Elsevier

    Valdemar Máximo, Paula Soares

  236. Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death

    Article • Journal of Biosciences, September 2011, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  237. Plenary Oral Free Paper Sessions

    Article • Virchows Archiv, August 2011, Springer Science + Business Media

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  238. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases

    Article • Virchows Archiv, July 2011, Springer Science + Business Media

    Paula Soares

  239. In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp

    Article • Endocrine Related Cancer, May 2011, Bioscientifica

    Paula Soares

  240. Abstract 1075: STAT3 signaling in thyroid cancer

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Paula Soares

  241. Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, March 2011, Elsevier

    Valdemar Máximo, Paula Soares

  242. Head and neck lesions in a cohort irradiated in childhood for tinea capitis treatment

    Article • The Lancet Infectious Diseases, March 2011, Elsevier

    Paula Soares

  243. Thyroid hormone as a regulator of tumor induced angiogenesis

    Article • Cancer Letters, February 2011, Elsevier

    Paula Soares

  244. Tumor-in-Tumor of the Thyroid With Basaloid Differentiation: A Lesion With a Solid Cell Nest Neoplastic Component?

    Article • International Journal of Surgical Pathology, January 2011, SAGE Publications

    Paula Soares

  245. Molecular Alterations in Sporadic Primary Hyperparathyroidism

    Article • Genetics Research International, January 2011, Hindawi Publishing Corporation

    Paula Soares

  246. Small papillary thyroid cancers—is BRAF of prognostic value?

    Article • Nature Reviews Endocrinology, January 2011, Springer Science + Business Media

    Paula Soares

  247. EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide

    Article • Journal of Cellular Biochemistry, January 2011, Wiley

    Paula Soares

  248. How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer

    Article • Journal of Thyroid Research, January 2011, Hindawi Publishing Corporation

    Paula Soares

  249. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics

    Article • Pigment Cell & Melanoma Research, November 2010, Wiley

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  250. Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

    Article • Oncogene, November 2010, Springer Science + Business Media

    Paula Soares

  251. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas

    Article • British Journal of Ophthalmology, August 2010, BMJ

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  252. Multicentre validation study of nucleic acids extraction from FFPE tissues

    Article • Virchows Archiv, July 2010, Springer Science + Business Media

    Paula Soares

  253. 95 Associations between functional EGFR polymorphisms and glioma risk

    Article • European Journal of Cancer Supplements, June 2010, Elsevier

    MD, PhD,IFCAP José Manuel Lopes, Paula Soares

  254. Hot Topics in Papillary Thyroid Carcinoma

    Article • International Journal of Surgical Pathology, May 2010, SAGE Publications

    Paula Soares

  255. Molecular Pathology of Thyroid Tumors: Diagnostic and Prognostic Relevance

    Article • International Journal of Surgical Pathology, May 2010, SAGE Publications

    Paula Soares

  256. Alopecia in women submitted to childhood X-ray epilation for tinea capitis treatment

    Article • British Journal of Dermatology, May 2010, Wiley

    Paula Soares

  257. Review Article: The Familial Counterparts of Follicular Cell—Derived Thyroid Tumors

    Article • International Journal of Surgical Pathology, May 2010, SAGE Publications

    Paula Soares

  258. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPAR ) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor

    Article • Endocrine Related Cancer, April 2010, Bioscientifica

    Paula Soares

  259. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma

    Article • Melanoma Research, April 2010, Wolters Kluwer Health

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  260. Abstract 3138: Stat3 signaling in thyroid cancer

    Article • Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Paula Soares

  261. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis

    Article • The Veterinary Journal, November 2009, Elsevier

    Valdemar Máximo, Paula Soares

  262. Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations

    Article • BMC Cancer, October 2009, Springer Science + Business Media

    Paula Soares

  263. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations

    Article • Histopathology, October 2009, Wiley

    Paula Soares

  264. IsBRAFmutation screening useful for preoperative risk stratification in papillary thyroid cancer?

    Article • Future Oncology, October 2009, Future Medicine

    Paula Soares

  265. BRAFV600Emutation in papillary thyroid carcinoma: a potential target for therapy?

    Article • Expert Review of Endocrinology & Metabolism, September 2009, Taylor & Francis

    Paula Soares

  266. Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer

    Article • Experimental Dermatology, June 2009, Wiley

    Paula Soares

  267. Mitochondria and cancer

    Article • Virchows Archiv, April 2009, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  268. How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer

    Article • Journal of Clinical Pathology, January 2009, BMJ

    Valdemar Máximo, Paula Soares

  269. Cribriform-Morular Variant of Papillary Thyroid Carcinoma

    Article • American Journal of Clinical Pathology, January 2009, Oxford University Press (OUP)

    Paula Soares

  270. Mitochondria and Oncocytomas

    Article • December 2008, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  271. Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation

    Article • Molecular Biology of the Cell, November 2008, American Society for Cell Biology (ASCB)

    Paula Soares

  272. Acquisition ofBRAFgene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma

    Article • Clinical Endocrinology, October 2008, Wiley

    Paula Soares

  273. Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth

    Article • Human Pathology, October 2008, Elsevier

    Paula Soares

  274. Optimization of methods to assess mitochondrial DNA in archival paraffin-embedded tissues from mammary canine tumors

    Article • Jornal Brasileiro de Patologia e Medicina Laboratorial, August 2008, FapUNIFESP (SciELO)

    Valdemar Máximo, Paula Soares

  275. Intragenic Mutations in Thyroid Cancer

    Article • Endocrinology and Metabolism Clinics of North America, June 2008, Elsevier

    Valdemar Máximo, Paula Soares

  276. GRIM-19 in Health and Disease

    Article • Advances in Anatomic Pathology, January 2008, Wolters Kluwer Health

    Valdemar Máximo, Paula Soares

  277. Mitochondria and Cancer

    Article • January 2008, Springer Science + Business Media

    Paula Soares

  278. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600E but not KRAS mutations

    Article • The Journal of Pathology, December 2007, Wiley

    Paula Soares

  279. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma

    Article • Familial Cancer, September 2007, Springer Science + Business Media

    Paula Soares

  280. Molecular and Genotypic Characterization of Human Thyroid Follicular Cell Carcinoma–Derived Cell Lines

    Article • Thyroid, August 2007, Mary Ann Liebert Inc

    Valdemar Máximo, Paula Soares

  281. Molecular genetics of papillary thyroid carcinoma: great expectations...

    Article • Arquivos Brasileiros de Endocrinologia & Metabologia, July 2007, FapUNIFESP (SciELO)

    Valdemar Máximo, Paula Soares

  282. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation

    Article • Virchows Archiv, May 2007, Springer Science + Business Media

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  283. Thyroid hormone receptor   mutations in the 'hot-spot region' are rare events in thyroid carcinomas

    Article • Journal of Endocrinology, January 2007, Bioscientifica

    Paula Soares

  284. B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas

    Article • Human Pathology, July 2006, Elsevier

    Paula Soares

  285. The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma

    Article • Human Pathology, May 2006, Elsevier

    Paula Soares

  286. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto‐oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal

    Article • Clinical Endocrinology, April 2006, Wiley

    Dr Maria joão Bugalho, Paula Soares

  287. Mutational Spectrum and Linkage Disequilibrium Patterns at the Ornithine Transcarbamylase Gene (OTC)

    Article • Annals of Human Genetics, March 2006, Wiley

    Paula Soares

  288. H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid

    Article • Oncogene, March 2006, Springer Science + Business Media

    Paula Soares

  289. PAX8-PPARγ Rearrangement Is Frequently Detected in the Follicular Variant of Papillary Thyroid Carcinoma

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2006, Endocrine Society

    Paula Soares

  290. Diagnostic Criteria in Well-Differentiated Thyroid Carcinomas

    Article • Endocrine Pathology, January 2006, Springer Science + Business Media

    Paula Soares

  291. Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas

    Article • Cancer Letters, December 2005, Elsevier

    Valdemar Máximo, Paula Soares

  292. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy

    Article • Mitochondrion, October 2005, Elsevier

    Valdemar Máximo, Paula Soares

  293. Molecular pathology of well-differentiated thyroid carcinomas

    Article • Virchows Archiv, September 2005, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  294. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma

    Article • Human Pathology, June 2005, Elsevier

    Paula Soares

  295. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

    Article • Virchows Archiv, May 2005, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  296. A stem cell role for thyroid solid cell nests

    Article • Human Pathology, May 2005, Elsevier

    Paula Soares

  297. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid

    Article • British Journal of Cancer, April 2005, Nature

    Valdemar Máximo, Paula Soares

  298. Cystic Tumor of the Atrioventricular Node of the Heart Appears to Be the Heart Equivalent of the Solid Cell Nests (Ultimobranchial Rests) of the Thyroid

    Article • American Journal of Clinical Pathology, March 2005, Oxford University Press (OUP)

    Paula Soares

  299. Cystic Tumor of the Atrioventricular Node of the Heart Appears to Be the Heart Equivalent of the Solid Cell Nests (Ultimobranchial Rests) of the Thyroid

    Article • American Journal of Clinical Pathology, March 2005, Oxford University Press (OUP)

    Paula Soares

  300. Hürthle (Oncocytic) Cell Tumors of Thyroid: Etiopathogenesis, Diagnosis and Clinical Significance

    Article • International Journal of Surgical Pathology, January 2005, SAGE Publications

    Valdemar Máximo, Paula Soares

  301. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes

    Article • The Journal of Pathology, January 2005, Wiley

    Paula Soares

  302. Mutation analysis of B-RAF gene in human gliomas

    Article • Acta Neuropathologica, November 2004, Springer Science + Business Media

    Paula Soares, MD, PhD,IFCAP José Manuel Lopes

  303. Mutated E-Cadherin: Genomic and Functional Characterization in Thyroid Cells from the KAT Family

    Article • Thyroid, November 2004, Mary Ann Liebert Inc

    Paula Soares

  304. BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2004, Endocrine Society

    Valdemar Máximo, Paula Soares

  305. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas

    Article • Virchows Archiv, April 2004, Springer Science + Business Media

    Paula Soares

  306. Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests

    Article • Modern Pathology, March 2004, Springer Science + Business Media

    Paula Soares

  307. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid

    Article • BMC Cancer, March 2004, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  308. BRAF mutations are associated with some histological types of papillary thyroid carcinoma

    Article • The Journal of Pathology, January 2004, Wiley

    Valdemar Máximo, Paula Soares

  309. Germline Succinate Dehydrogenase Subunit D Mutation Segregating with Familial Non-RET C Cell Hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2003, Endocrine Society

    Valdemar Máximo, Paula Soares

  310. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

    Article • Oncogene, July 2003, Nature

    Valdemar Máximo, Paula Soares

  311. E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas

    Article • Histopathology, June 2003, Wiley

    Paula Soares

  312. Immunohistochemical study of heat shock proteins 27, 60 and 70 in the normal human adrenal and in adrenal tumors with suppressed ACTH production

    Article • Microscopy Research and Technique, May 2003, Wiley

    Paula Soares

  313. Re: Lohrer,H.D., Hieber,L. and Zitzelsberger,H. (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis, 23, 1577-1582

    Article • Carcinogenesis, April 2003, Oxford University Press (OUP)

    Paula Soares

  314. Letter to the editor

    Article • Genes Chromosomes and Cancer, January 2003, Wiley

    Valdemar Máximo, Paula Soares

  315. Vascular Invasion in Thyroid and Gastric Carcinomas

    Article • Ultrastructural Pathology, January 2003, Taylor & Francis

    Paula Soares

  316. p63 Expression in Solid Cell Nests of the Thyroid: Further Evidence for a Stem Cell Origin

    Article • Modern Pathology, January 2003, Springer Science + Business Media

    Paula Soares

  317. Loss of Heterozygosity and Promoter Methylation, but not Mutation, May Underlie Loss of TFF1 in Gastric Carcinoma

    Article • Laboratory Investigation, October 2002, Elsevier

    Paula Soares

  318. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex

    Article • Virchows Archiv, May 2002, Springer Science + Business Media

    Valdemar Máximo, Paula Soares

  319. Mitochondrial DNA Somatic Mutations (Point Mutations and Large Deletions) and Mitochondrial DNA Variants in Human Thyroid Pathology

    Article • American Journal Of Pathology, May 2002, Elsevier

    Paula Soares

  320. Poorly Differentiated Carcinomas of the Thyroid Gland

    Article • International Journal of Surgical Pathology, April 2002, SAGE Publications

    Paula Soares

  321. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma

    Article • Journal of Medical Genetics, April 2002, BMJ

    Paula Soares

  322. Letter to the editors

    Article • Rheumatology International, January 2002, Springer Science + Business Media

    Paula Soares

  323. P63 Expression in Papillary and Anaplastic Carcinomas of the Thyroid Gland: Lack of an Oncogenetic Role in Tumorigenesis and Progression

    Article • Pathology - Research and Practice, January 2002, Elsevier

    Paula Soares

  324. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma

    Article • Virchows Archiv, December 2001, Springer Science + Business Media

    Paula Soares

  325. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma

    Article • Genes Chromosomes and Cancer, August 2001, Wiley

    Valdemar Máximo, Paula Soares

  326. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant

    Article • The Journal of Pathology, May 2001, Wiley

    Valdemar Máximo, Paula Soares

  327. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

    Article • Oncogene, March 2001, Springer Science + Business Media

    Paula Soares

  328. Fetal adenomas and minimally invasive follicular carcinomas of the thyroid frequently display a triploid or near triploid DNA pattern

    Article • Virchows Archiv, February 2001, Springer Science + Business Media

    Paula Soares

  329. Mitochondrial DNA alteration in gastric cancer

    Article • Gastroenterology, December 2000, Elsevier

    Valdemar Máximo, Paula Soares

  330. Extended structural variation of a pentanucleotide repeat in the GSTP1 gene: characterisation in a normal population and in thyroid and gastric tumours

    Article • European Journal of Human Genetics, July 2000, Springer Science + Business Media

    Paula Soares

  331. Clinicopathologic and prognostic significance of the expression of mucins, simple mucin antigens and histoblood group antigens in papillary thyroid carcinoma

    Article • Endocrine Pathology, December 1999, Springer Science + Business Media

    Paula Soares

  332. Papillary thyroid carcinoma overexpresses fully and underglycosylated mucins together with native and sialylated simple mucin antigens and histo-blood group antigens

    Article • Endocrine Pathology, December 1999, Springer Science + Business Media

    Paula Soares

  333. Comments on: Mutations in Mitochondrial Control Region DNA in Gastric Tumours of Japanese Patients, Tamura, et al. Eur J Cancer 1999, 35, 316–319

    Article • European Journal of Cancer, September 1999, Elsevier

    Valdemar Máximo, Paula Soares

  334. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas

    Article • European Journal of Cancer Prevention, August 1999, Wolters Kluwer Health

    Paula Soares

  335. Sporadicret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?

    Article • The Journal of Pathology, May 1998, Wiley

    Paula Soares

  336. The Common Deletion of Mitochondrial DNA is Found in Goiters and Thyroid Tumors with and Without Oxyphil Cell Change

    Article • Ultrastructural Pathology, January 1998, Taylor & Francis

    Valdemar Máximo, Paula Soares

  337. Article • Journal of Pediatric Orthopaedics, January 1998, Wolters Kluwer Health

    Paula Soares

  338. Prognosefaktoren bei differenzierten Schilddrüsenkarzinomen

    Article • Der Pathologe, August 1997, Springer Science + Business Media

    Paula Soares

  339. Benign and malignant thyroid lesions show instability at microsatellite loci

    Article • European Journal of Cancer, February 1997, Elsevier

    Paula Soares

  340. E-cadherin gene alterations are rare events in thyroid tumors

    Article • International Journal of Cancer, January 1997, Wiley

    Paula Soares

  341. Recent Advances in Cytometry, Cytogenetics and Molecular Genetics of Thyroid Tumours and Tumour-like Lesions

    Article • Pathology - Research and Practice, May 1995, Elsevier

    Paula Soares

  342. Chromosome analysis of 73 thyroid neoplasms

    Article • Cancer Genetics and Cytogenetics, October 1994, Elsevier

    Paula Soares

  343. Correspondence

    Article • Cancer, June 1994, Wiley

    Paula Soares

  344. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid

    Article • Histopathology, March 1994, Wiley

    Paula Soares

  345. Expression of C‐erb B2 in tumours and tumour‐like lesions of the thyroid

    Article • International Journal of Cancer, February 1994, Wiley

    Paula Soares

  346. Thyroid nodular hyperplasia

    Article • Cancer Genetics and Cytogenetics, August 1993, Elsevier

    Paula Soares

  347. Cytogenetic findings in eleven gastric carcinomas

    Article • Cancer Genetics and Cytogenetics, July 1993, Elsevier

    Paula Soares

  348. Cytogenetic findings in 18 follicular thyroid adenomas

    Article • Cancer Genetics and Cytogenetics, May 1993, Elsevier

    Paula Soares

  349. Clonal cytogenetic abnormalities and telomeric associations in a fibroxanthoma of the stomach

    Article • Genes Chromosomes and Cancer, November 1992, Wiley

    Paula Soares

  350. C-erbB-2 expression in primary gastric carcinomas and their metastases

    Article • Cancer Genetics and Cytogenetics, October 1992, Elsevier

    Paula Soares

  351. Loss of Y chromosome in gastric carcinoma

    Article • Cancer Genetics and Cytogenetics, July 1992, Elsevier

    Paula Soares

  352. Signet Ring Cell Carcinoma of the Stomach: A Morphometric, Ultrastructural, and DNA Cytometric Study

    Article • Ultrastructural Pathology, January 1992, Taylor & Francis

    Paula Soares